Enfusion, a leading SaaS provider for investment managers, announced strong financial results for Q4 2024, with total revenue increasing by 13.9% to $52.9 million and Adjusted EBITDA rising by 25.3% to $12.3 million. The company also reported an Annual Recurring Revenue (ARR) of $210.4 million, up 13.6% from the previous year, and a Net Dollar Retention Rate of 103.0%.

Enfusion reported a solid quarter with a 15.4% year-over-year revenue growth, driven by product initiatives and expansion outside of global money centers. The company narrowed its full year revenue guidance to $202M-$205M and Adjusted EBITDA guidance to $41M-$45M.

Enfusion reported a revenue of $49.5 million, representing a 16% year-over-year growth. The company won 39 new accounts and saw expansion of adjusted EBITDA margin.

Enfusion reported a strong start to 2024 with revenue growth of 17.3% year-over-year. The company saw an increase in new client wins and expanded its presence in Europe and Scandinavia. Average Contract Value increased sequentially. However, they reported a net loss of $0.761 million

Enfusion reported a strong Q3 2023, with revenue of $44.4 million, a 13.3% year-over-year growth. The company exceeded expectations and demonstrated the durability of its model, improving Adjusted EBITDA margins. They launched Portfolio WorkBench, expanded EBITDA margin, generated strong free cash flow, and signed new large clients.

Enfusion reported a balanced quarter with a 16.9% year-over-year revenue growth, driven by increasing client add counts, bookings, and average contract value, despite macroeconomic challenges.

Enfusion's Q1 2023 results showed double-digit revenue growth driven by new sales across products and services, with focused expense discipline maintaining a solid margin profile and strong cash conversion leading to positive adjusted free cash flow.

Enfusion reported strong financial results for Q3 2022, with total revenue growing to $39.2 million, a 35% increase year-over-year. The company added 43 new clients and saw growth in ARR and NDR. Net income was $2.6 million, and basic and diluted earnings per share were $0.02.

Enfusion announced strong Q2 2022 results, exceeding revenue and profitability expectations. Total revenue grew by 38% year-over-year, driven by new client signings and growth from existing clients. The company signed larger deals and added nine institutional asset managers, demonstrating its growing impact on larger funds globally.

Enfusion reported a 40% year-over-year increase in total revenue, reaching $34.1 million, driven by new client signings and growth from existing clients. The company added 42 new clients, including two seven-figure deals. However, the company experienced a net loss of $12.5 million, which includes $12.7 million in stock-based compensation.

Enfusion reported strong fourth-quarter results, driven by growth across all products and services. Revenue growth accelerated to 40% in 2021, with investment managers choosing Enfusion's cloud-native SaaS solution.

Enfusion reported strong Q3 2021 results, with total revenue reaching $29.0 million, a 46.8% increase year-over-year. The growth was driven by new client signings and expansion from existing clients. Net income was $3.3 million.